Question 1

What is Lumateperone used for?

Accepted Answer

Lumateperone (brand name Caplyta) is a Atypical Antipsychotic indicated for Schizophrenia, Bipolar Depression.

Question 2

How does Lumateperone work?

Accepted Answer

Lumateperone works through the following mechanism: Simultaneously modulates serotonin, dopamine, and glutamate neurotransmission via 5-HT2A antagonism, D2 partial agonism, and SERT inhibition..

Question 3

What are the most common side effects of Lumateperone?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for Lumateperone. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is Lumateperone the same as Caplyta?

Accepted Answer

Caplyta is a brand name for Lumateperone. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

Lumateperone

Mechanism of Action

Indications

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations